Literature DB >> 11775116

Serum levels of some cytokines and soluble adhesion molecules in normal and patients with malignant malaria in Zambia.

M M Gamra1, E M el-Sharkawy, C Shinondo.   

Abstract

The present study revealed no changes in the serum levels of IL-8 in malaria patients compared with controls. Such result however, does not exclude a role for IL-8 in falciparum malaria, as it is produced by activated endothelial cells that may be captured by receptors on the endothelial surface. This would allow local concentrations of IL-8 to be generated at the vessel wall without being shed into the circulation. The marked elevation of ICAM-1 and VCAM-1 in serum of falciparum malaria patients may support the concept that dysfunction of the endothelium is important in the pathophysiology of the disease. Increased level of IL-6 in serum of patients may contribute to endothelial damage and dysfunction by expression of endothelial adhesion molecules that in turn result in infected erythrocytes attraction to the endothelium and pathologic endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11775116

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  2 in total

1.  Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity.

Authors:  Aase Berg; Sam Patel; Miguel Gonca; Catarina David; Kari Otterdal; Thor Ueland; Ingvild Dalen; Jan T Kvaløy; Tom E Mollnes; Pål Aukrust; Nina Langeland
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

2.  Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria.

Authors:  Julie Bachmann; Florence Burté; Setia Pramana; Ianina Conte; Biobele J Brown; Adebola E Orimadegun; Wasiu A Ajetunmobi; Nathaniel K Afolabi; Francis Akinkunmi; Samuel Omokhodion; Felix O Akinbami; Wuraola A Shokunbi; Caroline Kampf; Yudi Pawitan; Mathias Uhlén; Olugbemiro Sodeinde; Jochen M Schwenk; Mats Wahlgren; Delmiro Fernandez-Reyes; Peter Nilsson
Journal:  PLoS Pathog       Date:  2014-04-17       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.